Who is the CEO of Materialise? Brigitte de Vet-Veithen’s Bio

Date
September 13, 2024

Brigitte de Vet-Veithen is the CEO of Materialise, a leading company in the 3D printing and software solutions industry. With over 20 years of experience in the healthcare sector, she has been instrumental in driving the company's growth and innovation.

Brigitte de Vet-Veithen's Email & LinkedIn

Brigitte de Vet-Veithen
materialise.com

Use Clay to find other emails

Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

You can also contact Brigitte de Vet-Veithen through his LinkedIn.

If you want to find further information about Brigitte de Vet-Veithen, like the phone number, or other people working at Materialise, sign up to Clay.

Who is the CEO of Materialise?

Brigitte de Vet-Veithen - CEO Materialise - Materialise | LinkedIn

Brigitte de Vet-Veithen has been a pivotal figure in the healthcare sector for over two decades. She took on the role of CEO at Materialise in January 2024, succeeding the company's co-founder, Fried Vancraen. Before her current position, she served as Vice President of Materialise Medical, where she played a crucial role in advancing the company's medical applications.

Her extensive experience and leadership have been instrumental in driving Materialise's growth and innovation in the 3D printing and personalized healthcare industries.

Work History

Brigitte de Vet-Veithen's extensive career history includes a variety of leadership roles across multiple organizations. Here is a detailed list of her previous positions:

  • Materialise - CEO Materialise (2024 - Present)
  • Materialise - VP Materialise, General Manager of Materialise Medical (2016 - Present)
  • Materialise - CEO-elect (2022 - 2024)
  • CAPRICORN HEALTH-TECH FUND - Chairwoman of the Board (2018 - Present)
  • Healthcare and Life Science Executive at De Vet Management - CTO and transformation lead at Mediq (2013 - 2015)
  • Healthcare and Life Science Executive at De Vet Management - CEO of Acertys group (2011 - 2013)
  • Healthcare and Life Science Executive at De Vet Management - Global portfolio & project management and Business Intelligence at GSK Bio (2009 - 2011)
  • Healthcare and Life Science Executive at De Vet Management - R&D program manager at Crucell (2008 - 2009)
  • Healthcare and Life Science Executive at De Vet Management - CEO of Monitor-IT (mobile health, spin-off from research center) (2007 - 2008)
  • Johnson and Johnson MD&D - General Manager Germany (2004 - 2007)
  • Johnson and Johnson MD&D - VP EMEA (2002 - 2004)
  • Johnson and Johnson MD&D - Business Director UK (2000 - 2002)
  • Johnson and Johnson MD&D - European Manager New Business Development (1999 - 2000)
  • Andersen Consulting - Senior Consultant (1996 - 1999)
  • DGM (Deutsche Bank / Roland Berger) - Consultant (1993 - 1996)

Education History

Brigitte de Vet-Veithen has a robust educational background that has significantly contributed to her successful career. She earned her MBA from INSEAD, completing the program between January 1998 and January 1999. Prior to that, she obtained a Master in Business with a major in engineering from HEC Liège, where she studied from January 1988 to January 1993. Additionally, she pursued a Bachelor of Business Administration (BBA) at Aston Business School, attending from January 1990 to January 1991. This diverse and comprehensive education has equipped her with the skills and knowledge necessary to excel in various leadership roles across the healthcare and 3D printing industries.

When did Brigitte de Vet-Veithen join Materialise?

Brigitte de Vet-Veithen joined Materialise in January 2016 as Vice President of Materialise Medical. She was later appointed as CEO-elect in January 2022, a role she held until she officially became the CEO on January 1, 2024. This marks her tenure at Materialise as spanning over seven years, during which she has played a significant role in the company's growth and innovation in the 3D printing and personalized healthcare sectors.

Share Article

More Articles